InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 14
Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / November 14, 2024 / The Company announces that on 13 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Flutter Entertainment PLC Announces Launch of Share Buyback Program
Flutter Entertainment announces launch of first tranche of share repurchase program DUBLIN, IRELAND AND TORONTO, ON / ACCESSWIRE / November 13, 2024 / Flutter Entertainment (NYSE:FLUT)(LSE:FLTR), the world's leading online sports betting and iGaming operator, announces that it has entered into non-discretionary arrangements with Goldman Sachs & Co LLC to repurchase ordinary shares on Flutter's behalf for an aggregate maximum consideration of up to $350 million on the New York Stock Exchange (the "Buyback"). The Buyback will commence November 14, 2024, on the New York Stock Exchange, and will end no later than 31 March 2025.The purpose of the Buyback is to reduce the share capital of Flutter.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 13
Purchase of own shares LONDON, UK / ACCESSWIRE / November 13, 2024 / The Company announces that on 12 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Flutter Entertainment PLC Announces Q3 2024 Financial Results
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER ASSIMILATED REGULATION (EU) NO. 596/2014 WHICH IS PART OF THE LAWS OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) NEW YORK, NY / ACCESSWIRE / November 12, 2024 / Flutter Entertainment (NYSE:FLUT)(LSE:FLTR), the world's leading online sports betting and iGaming operator, announces Q3 2024 results, and a small raise to fiscal year 2024 Group guidance.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 11
InterContinental Hotels Group PLC (the Company) Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / November 11, 2024 / The Company announces that on 08 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients
ANGLE plc ("the Company") DNA ANALYSIS OF PARSORTIX-ENRICHED CTCS AND CTDNA PROVIDES COMPLEMENTARY INFORMATION IN NSCLC PATIENTS TREATED WITH ASTRAZENECA'S OSIMERTINIB The addition of CTC-DNA analysis to clinical trials could identify patients developing treatment resistance prior to disease progression CTC analysis identifies druggable targets which could be used to inform combined targeted treatment GUILDFORD, SURREY / ACCESSWIRE / November 11, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of research investigating the dual analysis of CTCs and circulating tumour DNA (ctDNA) in non-small cell lung cancer (NSCLC), undertaken by the National and Kapodistrian University of Athens. Researchers used the Parsortix® system to isolate and harvest CTCs from 30 patients with EGFR-mutated NSCLC that were undergoing treatment with osimertinib (TAGRISSO: AstraZeneca).
Pantheon Resources PLC Announces Spudding of Megrez-1 well
Pantheon Resources plc Spudding of Megrez-1 well LONDON, UNITED KINGDOM / ACCESSWIRE / November 11, 2024 / Pantheon Resources plc (AIM:PANR)(OTCQX:PTHRF) ("Pantheon" or the "Company"), an oil and gas company developing the Kodiak and Ahpun oil fields in close proximity to pipeline and transportation infrastructure on Alaska's North Slope, today announces the spudding of the Megrez-1 well to explore the eastern topsets in the Ahpun field, immediately adjacent to pipeline and road infrastructure. The reservoir sections to be targeted are both younger and shallower than in any of Pantheon's previous Alaskan wells, with superior reservoir characteristics predicted.
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
Institutional Investment of £600,000 Hemogenyx Pharmaceuticals Secures £0.6m for Phase I Clinical Trials LONDON, UNITED KINGDOM / ACCESSWIRE / November 11, 2024 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO), the biopharmaceutical group focused on developing new therapies for blood diseases, is pleased to announce that it was approached by an institutional investor and that this investor has subscribed £600,000, for the issue of 60,000,000 new Ordinary Shares at 1p per share. The net proceeds of this subscription will be dedicated to the imminent commencement of the Phase I clinical trials for the Company's Chimeric Antigen Receptor T-cell therapy ("HEMO-CAR-T" or "HG-CT-1"), aimed at treating acute myeloid leukemia ("AML").
Rio Tinto, Anglo American slump as latest Chinese stimulus underwhelms
London-listed Miners faced a blow on Friday as China's latest attempts to prop up its struggling economy underwhelmed. Copper firm Antofagasta PLC (LSE:ANTO) dropped 4.9% over the course of the morning, as Rio Tinto PLC, Anglo American PLC (LSE:AAL) and Glencore PLC (LSE:GLEN) also sat among the FTSE 100's losers.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 08
Purchase of own shares LONDON, UK / ACCESSWIRE / November 8, 2024 / The Company announces that on 07 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Argo Blockchain PLC Announces Baie Comeau and Helios Updates
Baie Comeau, High Performance Computing and Helios Updates LONDON, UNITED KINGDOM / ACCESSWIRE / November 7, 2024 / Argo Blockchain plc, a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ:ARBK), is pleased to provide the following update: Baie-Comeau and High Performance Computing (HPC) Argo has entered into a non-binding letter of intent ("LOI") with BE Global Development Limited ("BE"), a specialist in HPC solutions, to explore a significant expansion at the Company's owned and operated Baie-Comeau facility. This proposed expansion would involve deploying advanced HPC infrastructure, which would diversify Argo's capabilities beyond Bitcoin mining into high-performance computing, positioning the Company to serve broader computing applications in data processing, AI, and other computationally intensive tasks.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 07
LONDON, UNITED KINGDOM / ACCESSWIRE / November 7, 2024 / The Company announces that on 06 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
